Capital Nasdaq (Taiwan) Performance

00678 Etf  TWD 29.88  0.05  0.17%   
The etf shows a Beta (market volatility) of 0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Capital Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding Capital Nasdaq is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capital Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Capital Nasdaq is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Fifty Two Week Low21.35
Fifty Two Week High30.28
  

Capital Nasdaq Relative Risk vs. Return Landscape

If you would invest  3,044  in Capital Nasdaq Biotechnology on September 5, 2024 and sell it today you would lose (56.00) from holding Capital Nasdaq Biotechnology or give up 1.84% of portfolio value over 90 days. Capital Nasdaq Biotechnology is generating negative expected returns and assumes 1.0578% volatility on return distribution over the 90 days horizon. Simply put, 9% of etfs are less volatile than Capital, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Capital Nasdaq is expected to under-perform the market. In addition to that, the company is 1.42 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.21 per unit of volatility.

Capital Nasdaq Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Capital Nasdaq's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Capital Nasdaq Biotechnology, and traders can use it to determine the average amount a Capital Nasdaq's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0226

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns00678

Estimated Market Risk

 1.06
  actual daily
9
91% of assets are more volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Capital Nasdaq is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Capital Nasdaq by adding Capital Nasdaq to a well-diversified portfolio.

Capital Nasdaq Fundamentals Growth

Capital Etf prices reflect investors' perceptions of the future prospects and financial health of Capital Nasdaq, and Capital Nasdaq fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Capital Etf performance.

About Capital Nasdaq Performance

Assessing Capital Nasdaq's fundamental ratios provides investors with valuable insights into Capital Nasdaq's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Capital Nasdaq is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
CAPITAL SECURITIES is traded on Taiwan Stock Exchange in Taiwan.
Capital Nasdaq Biote generated a negative expected return over the last 90 days
The fund holds 98.58% of its total net assets in equities

Other Information on Investing in Capital Etf

Capital Nasdaq financial ratios help investors to determine whether Capital Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Capital with respect to the benefits of owning Capital Nasdaq security.